Diazoxide‐induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom

Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism

(2019) Paul Thornton et al.   Hormone Research in Paediatrics

Prevalence of Adverse Events in Children with Congenital Hyperinsulinism Treated with Diazoxide

(2018) Adriana Herrera et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review

(2017) Matthew R. Timlin et al.   PEDIATRIC CARDIOLOGY

Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children

(2016) Christine Ferrara et al.   JOURNAL OF PEDIATRICS

High Prevalence of Severe Circulatory Complications with Diazoxide in Premature Infants

(2014) Kayo Yoshida et al.   Neonatology

Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism

(2013) Hima Bindu Avatapalle et al.   Frontiers in Endocrinology

Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy

(2008) Dincer Yildizdas et al.   ADVANCES IN THERAPY